Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E-Prescribing Exception From Anti-Kickback Laws Proposed By CMS

Executive Summary

The Centers for Medicare & Medicaid Services will issue a proposed rule to create partial exemption from anti-kickback laws for e-prescribing incentives

You may also be interested in...



E-Prescribing Will Diminish Importance Of Drug Marketing, PCMA Says

The advent of electronic prescribing will diminish the importance of pharmaceutical companies' marketing efforts, Pharmaceutical Care Management Association President Mark Merritt said

E-Prescribing Will Diminish Importance Of Drug Marketing, PCMA Says

The advent of electronic prescribing will diminish the importance of pharmaceutical companies' marketing efforts, Pharmaceutical Care Management Association President Mark Merritt said

PBMs Object To Real-Time Prior Authorization In E-Prescribing

Several pharmacy benefit managers are opposing making real-time prior authorization part of electronic prescribing systems

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel